Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Boulding Mark Elliott
EXEC. VP AND CLO at PTC THERAPEUTICS. Filing since 20 Mar 2014.
CIK 0001578852
Company
Date
Role
Action
Shares
Amount
Of holding
PTCT
PTC THERAPEUTICS, INC.
6 Oct 2026
EXEC. VP AND CLO
Sold on a plan
435
$27.91K
0.4%
PTCT
PTC THERAPEUTICS, INC.
5 Oct 2026
EXEC. VP AND CLO
Sold on a plan
1,638
$104.88K
1.5%
PTCT
PTC THERAPEUTICS, INC.
17 Aug 2026
EXEC. VP AND CLO
Sold on a plan
2,813
$204.13K
2.6%
PTCT
PTC THERAPEUTICS, INC.
6 Jul 2026
EXEC. VP AND CLO
Sold on a plan
5,079
$432.12K
4.6%
PTCT
PTC THERAPEUTICS, INC.
17 Jun 2026
EXEC. VP AND CLO
Sold on a plan
10,462
$822.87K
9.0%
PTCT
PTC THERAPEUTICS, INC.
15 May 2026
EXEC. VP AND CLO
Sold on a plan
2,812
$202.96K
2.6%
PTCT
PTC THERAPEUTICS, INC.
8 May 2026
EXEC. VP AND CLO
Sold on a plan
3,540
$279.57K
3.3%
PTCT
PTC THERAPEUTICS, INC.
6 Apr 2026
EXEC. VP AND CLO
Sold on a plan
2,265
$157.29K
2.1%
PTCT
PTC THERAPEUTICS, INC.
19 Feb 2026
EXEC. VP AND CLO
Sold on a plan
3,019
$209.76K
2.8%
PTCT
PTC THERAPEUTICS, INC.
18 Feb 2026
EXEC. VP AND CLO
Sold on a plan
3,081
$213.70K
2.8%
PTCT
PTC THERAPEUTICS, INC.
17 Feb 2026
EXEC. VP AND CLO
Sold on a plan
2,813
$194.91K
2.5%
PTCT
PTC THERAPEUTICS, INC.
9 Jan 2026
EXEC. VP AND CLO
Sold on a plan
2,314
$180.32K
2.0%
PTCT
PTC THERAPEUTICS, INC.
8 Jan 2026
EXEC. VP AND CLO
Sold on a plan
4,033
$308.76K
3.4%
PTCT
PTC THERAPEUTICS, INC.
7 Jan 2026
EXEC. VP AND CLO
Sold on a plan
4,879
$377.83K
4.0%
PTCT
PTC THERAPEUTICS, INC.
6 Jan 2026
EXEC. VP AND CLO
Sold on a plan
1,739
$133.82K
1.4%
PTCT
PTC THERAPEUTICS, INC.
5 Jan 2026
EXEC. VP AND CLO
Sold on a plan
2,266
$171.19K
1.8%
PTCT
PTC THERAPEUTICS, INC.
17 Nov 2025
EXEC. VP AND CLO
Sold on a plan
2,812
$213.69K
2.6%
PTCT
PTC THERAPEUTICS, INC.
7 Oct 2025
EXEC. VP AND CLO
Sold on a plan
3,375
$214.09K
3.1%
PTCT
PTC THERAPEUTICS, INC.
6 Oct 2025
EXEC. VP AND CLO
Sold on a plan
2,266
$147.45K
2.1%
PTCT
PTC THERAPEUTICS, INC.
3 Oct 2025
EXEC. VP AND CLO
Sold on a plan
22,655
$1.49M
17.9%
PTCT
PTC THERAPEUTICS, INC.
12 Sep 2025
EXEC. VP AND CLO
Sold on a plan
24,585
$1.51M
19.1%
PTCT
PTC THERAPEUTICS, INC.
11 Sep 2025
EXEC. VP AND CLO
Sold on a plan
22,664
$1.38M
17.9%
PTCT
PTC THERAPEUTICS, INC.
15 Aug 2025
EXEC. VP AND CLO
Sold on a plan
2,813
$136.66K
2.6%
PTCT
PTC THERAPEUTICS, INC.
16 May 2025
EXEC. VP AND CLO
Sold at will
883
$40.64K
0.8%
PTCT
PTC THERAPEUTICS, INC.
15 May 2025
EXEC. VP AND CLO
Sold at will
1,929
$89.08K
1.8%
PTCT
PTC THERAPEUTICS, INC.
12 Mar 2025
EXEC. VP AND CLO
Sold on a plan
15,521
$827.23K
13.0%
PTCT
PTC THERAPEUTICS, INC.
11 Mar 2025
EXEC. VP AND CLO
Sold on a plan
7,381
$391.32K
6.6%
PTCT
PTC THERAPEUTICS, INC.
10 Mar 2025
EXEC. VP AND CLO
Sold on a plan
68,039
$3.61M
39.6%
PTCT
PTC THERAPEUTICS, INC.
20 Feb 2025
EXEC. VP AND CLO
Sold on a plan
1,614
$80.90K
1.5%
PTCT
PTC THERAPEUTICS, INC.
19 Feb 2025
EXEC. VP AND CLO
Sold on a plan
1,333
$66.78K
1.2%
PTCT
PTC THERAPEUTICS, INC.
8 Jan 2025
EXEC. VP AND CLO
Sold on a plan
1,998
$88.91K
1.8%
PTCT
PTC THERAPEUTICS, INC.
7 Jan 2025
EXEC. VP AND CLO
Sold on a plan
1,543
$69.96K
1.4%
PTCT
PTC THERAPEUTICS, INC.
3 Dec 2024
EXEC. VP AND CLO
Sold on a plan
10,308
$549.05K
10.0%
PTCT
PTC THERAPEUTICS, INC.
2 Dec 2024
EXEC. VP AND CLO
Sold on a plan
85,600
$4.47M
48.1%
PTCT
PTC THERAPEUTICS, INC.
30 Jan 2024
EXEC. VP AND CLO
Sold on a plan
794
$21.64K
1.1%
PTCT
PTC THERAPEUTICS, INC.
9 Jan 2024
EXEC. VP AND CLO
Sold on a plan
1,938
$56.23K
2.6%
PTCT
PTC THERAPEUTICS, INC.
8 Jan 2024
EXEC. VP AND CLO
Sold on a plan
1,457
$41.73K
1.9%
PTCT
PTC THERAPEUTICS, INC.
17 Apr 2023
EXEC. VP AND CLO
Sold on a plan
61,923
$3.18M
45.1%
PTCT
PTC THERAPEUTICS, INC.
31 Jan 2023
EXEC. VP AND CLO
Sold, plan not stated
812
$37.05K
1.1%
PTCT
PTC THERAPEUTICS, INC.
11 Jan 2023
EXEC. VP AND CLO
Sold, plan not stated
495
$21.96K
0.6%
PTCT
PTC THERAPEUTICS, INC.
10 Jan 2023
EXEC. VP AND CLO
Sold, plan not stated
590
$25.33K
0.8%
PTCT
PTC THERAPEUTICS, INC.
9 Jan 2023
EXEC. VP AND CLO
Sold, plan not stated
835
$34.78K
1.1%
PTCT
PTC THERAPEUTICS, INC.
18 Oct 2022
EXEC. VP AND CLO
Sold, plan not stated
299
$16.46K
0.5%
PTCT
PTC THERAPEUTICS, INC.
17 Oct 2022
EXEC. VP AND CLO
Sold, plan not stated
6,602
$363.11K
9.8%
PTCT
PTC THERAPEUTICS, INC.
20 Sep 2022
EXEC. VP AND CLO
Sold, plan not stated
1,176
$64.68K
1.9%
PTCT
PTC THERAPEUTICS, INC.
13 Apr 2022
EXEC. VP AND CLO
Sold, plan not stated
2,276
$102.81K
3.6%
PTCT
PTC THERAPEUTICS, INC.
5 Apr 2022
EXEC. VP AND CLO
Sold, plan not stated
5
$225.00
0.0%
PTCT
PTC THERAPEUTICS, INC.
10 Feb 2022
Exec. VP and CLO
Sold, plan not stated
17,935
$807.56K
22.7%
PTCT
PTC THERAPEUTICS, INC.
1 Feb 2022
Exec. VP and CLO
Sold, plan not stated
779
$31.16K
1.3%
PTCT
PTC THERAPEUTICS, INC.
7 Jan 2022
Exec. VP and CLO
Sold, plan not stated
885
$34.09K
1.8%
PTCT
PTC THERAPEUTICS, INC.
2 Sep 2021
Exec. VP and CLO
Sold, plan not stated
3,363
$151.38K
6.5%
PTCT
PTC THERAPEUTICS, INC.
9 Jul 2021
Exec. VP and CLO
Sold, plan not stated
1,429
$64.31K
2.9%
PTCT
PTC THERAPEUTICS, INC.
8 Jul 2021
Exec. VP and CLO
Sold, plan not stated
7,805
$352.97K
13.9%
PTCT
PTC THERAPEUTICS, INC.
1 Feb 2021
Exec. VP and CLO
Sold, plan not stated
778
$44.31K
1.6%
PTCT
PTC THERAPEUTICS, INC.
5 Jan 2021
Exec. VP and CLO
Sold, plan not stated
772
$48.15K
1.9%
PTCT
PTC THERAPEUTICS, INC.
7 Jul 2020
Exec. VP and CLO
Sold, plan not stated
30,625
$1.69M
43.5%
PTCT
PTC THERAPEUTICS, INC.
5 Jul 2019
Exec. VP and CLO
Sold, plan not stated
15,312
$685.10K
34.2%
PTCT
PTC THERAPEUTICS, INC.
1 Jul 2019
Exec. VP and CLO
Sold, plan not stated
104,092
$4.68M
77.9%
PTCT
PTC THERAPEUTICS, INC.
28 Jun 2019
Exec. VP and CLO
Sold, plan not stated
77,575
$3.49M
72.4%
PTCT
PTC THERAPEUTICS, INC.
8 Jun 2015
Exec VP and CLO
Sold, plan not stated
56,849
$3.13M
77.7%
PTCT
PTC THERAPEUTICS, INC.
20 Mar 2015
Exec. VP and CLO
Sold, plan not stated
21,142
$1.44M
65.6%
PTCT
PTC THERAPEUTICS, INC.
20 Mar 2014
Exec. VP and CLO
Sold, plan not stated
10,049
$311.12K
23.8%
62 decisions on file.
